Long-term outcomes of pulmonary embolism in children and adolescents
This cohort study describes the long-term outcomes of PE in 150 children and adolescents followed-up at a single-center institution.Patients were screened for a
This cohort study describes the long-term outcomes of PE in 150 children and adolescents followed-up at a single-center institution.Patients were screened for a
In this issue of Blood, Liu and colleagues report the preliminary characterization of a new BCL2-specific inhibitor (BCL2i), sonrotoclax, which not only bi
In this issue of Blood, Chan et al report on in-depth studies of identical twins with idiopathic multicentric Castleman disease (iMCD), which provides a un
T-cell help in the TME enhances rituximab-mediated NK-cell viability, CD16 and CD25 expression, and antitumor response.
In this issue of Blood, Chan et al report on in-depth studies of identical twins with idiopathic multicentric Castleman disease (iMCD), which provides a un
Expanding the HLA-I–restricted MiHA repertoire by 81 new antigens reveals that MiHAs are often recurrently targeted in multiple patients.Of all 159 MiHAs,
Human FcγRIII monovalent blocking as a 1-armed antibody or albumin fusion protein are effective in a humanized model of ITP.The monovalent albumin fusion p
LIVE WEBINAR: Wednesday, May 8, 2024 | 5:00 PM – 6:00 PM Eastern Time (ET) Register for this complimentary event with the “Register Now” button…
In this issue of Blood, Mingot-Castellano et al, on behalf of the Spanish Apheresis Group and the Spanish Thrombotic Thrombocytopenic Purpura Registry, pre
The novel EHA/EBMT grading of ICAHT closely reflects the extent of hematological toxicity following BCMA- and CD19-directed CAR-T therapy.Severe ICAHT was
Key Points. CAR-T cell therapy demonstrates superior efficacy to bispecific antibody in DLBCL treatment, with higher complete response rates.CAR-T cell the